Results 231 to 240 of about 3,752,482 (246)

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates†‡

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg
exaly  

Improving patient and caregiver outcomes in oncology: Team-based, timely, and targeted palliative care

Ca-A Cancer Journal for Clinicians, 2018
Eduardo Bruera, David Hui, Camilla Zimmermann   +2 more
exaly  

Combining immunotherapy and targeted therapies in cancer treatment

Nature Reviews Cancer, 2012
Matthew W Vanneman
exaly  

Combine and conquer: challenges for targeted therapy combinations in early phase trials

Nature Reviews Clinical Oncology, 2016
Juanita Lopez, Udai Banerji
exaly  

Targeted therapies: how personal should we go?

Nature Reviews Clinical Oncology, 2011
Salvatore Siena, Miriam Martini, Alberto Bardelli   +2 more
exaly  

Tumor control versus adverse events with targeted anticancer therapies

Nature Reviews Clinical Oncology, 2011
Dorothy M K Keefe
exaly  

Targeted agents and immunotherapies: optimizing outcomes in melanoma

Nature Reviews Clinical Oncology, 2017
Georgina V. Long, Jason J Luke, Keith Flaherty   +2 more
exaly  

Targeted therapy in non-small-cell lung cancer—is it becoming a reality?

Nature Reviews Clinical Oncology, 2010
David J Stewart, Filip Janku, Razelle Kurzrock   +2 more
exaly  

Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements

Nature Reviews Drug Discovery, 2010
Joseph Tomaszewski
exaly  

The influence of subclonal resistance mutations on targeted cancer therapy

Nature Reviews Clinical Oncology, 2015
Lawrence A Loeb, Jesse J Salk, Michael W Schmitt   +2 more
exaly